Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002750795 | SCV003010075 | uncertain significance | UDPglucose-4-epimerase deficiency | 2022-06-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with GALE-related conditions. This sequence change falls in intron 6 of the GALE gene. It does not directly change the encoded amino acid sequence of the GALE protein. This variant is not present in population databases (gnomAD no frequency). |